Table 2.
DMARD use in idiopathic and JIA uveitis
| Drug | Idiopathic Uveitis | JIA Uveitis |
|---|---|---|
| N = 92 (%) | N = 643 (%) | |
| Methotrexate | 70 (76) | 549 (85) |
| Oral | 44 (48) | 375 (58) |
| SQ | 46 (50) | 416 (65) |
| Mycophenolate mofetil | 9 (10) | 33 (5) |
| Cyclosporine | 3 (3) | 20 (3) |
| Sulfasalazine | 1 (1) | 47 (7) |
| Hydroxychloroquine | 0 (0) | 27 (4) |
| Leflunomide | 0 (0) | 20 (3) |
| Tacrolimus | 0 (0) | 8 (1) |
| Azathioprine | 0 (0) | 3 (0.4) |
| Cyclophosphamide | 0 (0) | 1 (0.2) |
Data in this table represent “ever drug use” in patients with data available on DMARD drug exposure (92/92 patients with idiopathic uveitis and 643/646 patients with JIA uveitis)
JIA juvenile idiopathic arthritis, SQ subcutaneous